InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by FINKELSTEIN J J, Chief Executive Officer. Officer active across 1 companies, notably Regenerx Biopharmaceuticals INC. Cumulatively, 2 reports have been logged. Total volume traded: €25k. The latest transaction was disclosed on 30 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€12,65175,000 shares@ €0.1687100.0% of flow
Common Stock
SEC:0000914190-21-000193·
Ideal exit: 27 Mar 2022 (T+270)
€12,65175,000 shares@ €0.168750.0% of flow
Common Stock
SEC:0000914190-21-000193:0·
Ideal exit: 27 Mar 2022 (T+270)
2 of 2 declarations
About FINKELSTEIN J J
FINKELSTEIN J J serves as President and CEO at Regenerx Biopharmaceuticals Inc. He is responsible for the strategic and operational direction of the company. J J plays a key role in business development and technological innovation, contributing to the growth of Regenerx. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.
